AI-human collaboration in a "Virtual Lab" successfully designs and experimentally validates nanobodies with enhanced binding ...

The company is paying China-based biotech LaNova Medicines $588 million for the kind of dual-pronged antibody drug that ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...